期刊文献+

中药活血通络法佐治糖尿病周围神经病变52例疗效观察 被引量:1

Effective observation on treating 52 cases of diabetic peripheral neuropathy by TCM activating blood and collaterals
下载PDF
导出
摘要 目的:观察中药活血通络法佐治糖尿病周围神经病变(DPN)的疗效及安全性。方法:100例DPN患者按随机数字表法分为两组,两组均在血糖控制稳定后开始观察,对照组52例给予甲钴胺注射液和丁咯地尔注射液静脉滴注,1次/d;观察组48例在对照组治疗基础上采用活血通络法(中药内服兼外敷),2次/d。2组疗程均为30d。观察治疗前后临床症状、体征、运动神经传导速度(MNCV)及感觉神经传导速度(SNCV)等指标的改变。结果:观察组总有效率显著高于对照组(P〈0.05);观察组的4项神经传导速度均显著高于对照组(P均〈0.05)。两组治疗期间均无严重的不良反应。结论:中药活血通络法佐治糖尿病周围神经病变安全有效,中西医结合治疗有协同作用。 Objective: To observe the effect and security of treating diabetic peripheral neuropathy by TCM activating blood and collaterals (DPN). Methods: 100 patients with DPN were divided into two groups by random number table, both groups began to observe after the blood sugar had stabilized. Control group (48 cases) received intravenous infusion of Methylcobalamin Injection and Buflomedil injection,one time a day; Observation group (52 cases) were treated with activating blood and collaterals (oral and external application of Chinese Herbs) on the basis of the control group. The treatment course of 2 groups was 30 days. Before and after treatment, clinical symptoms, signs, motor nerve conduction velocity (MNCV) and sensory nerve conduction velocity (SNCV) and other indicators were observed. Results: The total effective rate of the observation group was significantly higher than the control group (P〈0.05); Four indicators of nerve conduction velocity were significantly higher than the observation group (P〈0.05). 2 groups were no serious adverse events during treatment. Conclusion: Treating diabetic peripheral neuropathy by TCM activating blood and collaterals is safe and effective, the intergartive medicine has synergistic effect.
出处 《中医临床研究》 2010年第15期100-102,共3页 Clinical Journal Of Chinese Medicine
关键词 2型糖尿病 糖尿病周围神经病变 甲钴胺 丁咯地尔 中医药疗法 Type 2 diabetes Diabetic peripheral neuropathy Methylcobalamin Buflomedil TCM thorapy
  • 相关文献

参考文献7

二级参考文献24

  • 1迟志波.盐酸丁咯地尔治疗糖尿病神经病变59例临床观察[J].山东医药,2004,44(28):54-55. 被引量:5
  • 2王桂侠,宋国培,郝守才,李广仁,江新梅,林世和.糖尿病神经病变患者的神经病理变化[J].中国糖尿病杂志,1997,5(2):113-113. 被引量:28
  • 3汤晓英.神经系统临床生理学(下)[M].北京:人民军医出版社,2003:44—45.
  • 4[4]Bhatt HR,Lime JC,Matthew DM.Can faulty vitamin B12(Cobalamin) metabolism produce diabetic neuropathy[J].Lancet,1983,2(2):57
  • 5Ossipov MH, Porreca F. Challenges in the development of novel treatment strategies for neuropathic pain. NeuroRx, 2005,2 : 650-661.
  • 6Zhao P, Waxman SG, Hains BC,et al.Sodium channel expression in the ventral posterolateral nucleus of the thalamus after peripheral nerve injury. Mol Pain,2006,2:27.
  • 7Snutch TP.Targeting chronic and neuropathic pain: The N-type calcium channel comes of age. NeuroRx, 2005,2 : 662-670.
  • 8Anitha M, Gondha C, Sutliff R, et al. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest, 2006,116: 344-356.
  • 9Obrosova IG, Li F, Abatan OI, et al. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes,2004,53:711-720.
  • 10Conn KJ, Ullman MD, Eisenhauer PB, et al. Decreased expression of the NADH; ubiquinone oxidoreductase (complex Ⅰ )subunit 4 in 1-methyl-4-phenylpyridinium-treated human neuroblastoma SH-SY5Y cells. Neurosci Lett, 2001,36:145-148.

共引文献56

同被引文献3

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部